Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / BIOTECH ETF
-
Total 13F shares
-
973,433
-
Share change
-
-102,863
-
Total reported value
-
$151,595,523
-
Price per share
-
$155.73
-
Number of holders
-
111
-
Value change
-
-$16,056,546
-
Number of buys
-
29
-
Number of sells
-
39
Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q3 2023
As of 30 Sep 2023,
VANECK ETF TRUST - BIOTECH ETF (BBH) was held by
111 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
973,433 shares.
The largest 10 holders included
Miller Investment Management, LP, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, LPL Financial LLC, Consolidated Investment Group LLC, COMMONWEALTH EQUITY SERVICES, LLC, UBS Group AG, and Royal Bank of Canada.
This page lists
111
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.